Sedation
Prashant Choudhary, BDS,MDS
Resident
Boston University, Boston, MA
Boston University
Lexington, Massachusetts, United States
Christine Chiao, MPH, DMD
Clinical Assistant Professor
Boston University, Boston, MA
Boston University Goldman School of Dental Medicine
Boston, Massachusetts, United States
Keri Discepolo, DDS, MPH
Program Director, Pediatric Dentistry
Boston University
Boston, Massachusetts, United States
Purpose: The study aims to evaluate the impact of BMI on the effectiveness of oral midazolam combined with nitrous oxide inhalation for sedating pediatric dental patients.
Materials: This retrospective chart review analyzed dental records of children aged 12 and under who received oral sedation with benzodiazepine at the Franciscan Children’s Pediatric Dentistry Clinic between March 2021 and March 2023. Data was extracted from complete, de-identified sedation records, including sedation dosage, ASA status, vital signs, procedure type, recovery time, and sedation effectiveness. The patients were divided into 3 groups: Underweight (BMI < 5th percentile); Normal weight (BMI 5th to 85th percentile); and Overweight/Obsese (BMI >85th percentile). Sedation effectiveness was evaluated through the following variables: pre- and post-sedation Houpt behavior rating scale during sedation (overall behavior), and overall effectiveness. Data entry was completed using Microsoft Excel and analyzed using Microsoft Excel and SPSS software.
Results: There was a total of 323 subjects, with an average age of 6.5 ± 2.18 and an average BMI percentile of 58.01%. Statistical analysis including comparison between BMI categories is pending.
Conclusion: Conclusions are pending.
Identify Supporting Agency and Grant Number: